STAT | Reporting from the frontiers of health and medicine Follow Opinion: The FDA’s pivot from ad comms to ‘expert’ panels is bad medicine G. Caleb Alexander has chaired or served on more than a dozen FDA advisory committees. He’s worried the shift to ‘expert’ panels lacks transparency. https://www.statnews.com/2025/09/05/fda-expert-panels-advisory-committees-talc-ssris-formula/ statnews.com
